Better data needed from pregnancy registries

Gerald G. Briggs, Janine Polifka, Elizabeth Balken, Anick Berard, Stephen Braddock, Christina Chambers, Adrienne Einarson, Cecilia Lyons Gaffaney, Dee Quinn, Gideon Koren, Kenneth Jones, Steve Lamm, Richard Miller, Sara Riordan, Luther Robinson, Offie Soldin, Katherine Wisner, Lori Wolfe

Research output: Contribution to journalShort survey

15 Citations (Scopus)

Abstract

This article is a consensus position statement from the Research Committee of the Organization of Teratology Information Specialists (OTIS). The Committee believes that more specific information on the timing and dose of drug exposures from pregnancy birth defect registries sponsored by pharmaceutical companies (herein called pregnancy registries) would improve the estimation of risk for developmental toxicity (i.e., growth alteration, structural anomalies, functional/neurobehavioral deficits, or death). Specifically, the Committee believes that the exposure timing should be stated in gestational weeks and days rather than simply weeks. In addition, the Committee believes that the exposure dose should be stated in patient-specific terms, such as body weight (mg/kg) or body surface area (mg/m2) rather than simply dose strength. Although the focus of this position is pregnancy registries, it also is applicable to any source of medication-induced embryo-fetal toxicity.

Original languageEnglish (US)
Pages (from-to)109-111
Number of pages3
JournalBirth Defects Research Part A - Clinical and Molecular Teratology
Volume85
Issue number2
DOIs
StatePublished - Feb 1 2009

Fingerprint

Registries
Pregnancy
Body Surface Area
Pharmaceutical Preparations
Embryonic Structures
Body Weight
Growth
Research

Keywords

  • Exposure dose
  • Exposure timing
  • Pregnancy registries

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Embryology
  • Developmental Biology

Cite this

Briggs, G. G., Polifka, J., Balken, E., Berard, A., Braddock, S., Chambers, C., ... Wolfe, L. (2009). Better data needed from pregnancy registries. Birth Defects Research Part A - Clinical and Molecular Teratology, 85(2), 109-111. https://doi.org/10.1002/bdra.20551
Briggs, Gerald G. ; Polifka, Janine ; Balken, Elizabeth ; Berard, Anick ; Braddock, Stephen ; Chambers, Christina ; Einarson, Adrienne ; Gaffaney, Cecilia Lyons ; Quinn, Dee ; Koren, Gideon ; Jones, Kenneth ; Lamm, Steve ; Miller, Richard ; Riordan, Sara ; Robinson, Luther ; Soldin, Offie ; Wisner, Katherine ; Wolfe, Lori. / Better data needed from pregnancy registries. In: Birth Defects Research Part A - Clinical and Molecular Teratology. 2009 ; Vol. 85, No. 2. pp. 109-111.
@article{43d1f50450ed40eeaa3b1f0eb1a58dc2,
title = "Better data needed from pregnancy registries",
abstract = "This article is a consensus position statement from the Research Committee of the Organization of Teratology Information Specialists (OTIS). The Committee believes that more specific information on the timing and dose of drug exposures from pregnancy birth defect registries sponsored by pharmaceutical companies (herein called pregnancy registries) would improve the estimation of risk for developmental toxicity (i.e., growth alteration, structural anomalies, functional/neurobehavioral deficits, or death). Specifically, the Committee believes that the exposure timing should be stated in gestational weeks and days rather than simply weeks. In addition, the Committee believes that the exposure dose should be stated in patient-specific terms, such as body weight (mg/kg) or body surface area (mg/m2) rather than simply dose strength. Although the focus of this position is pregnancy registries, it also is applicable to any source of medication-induced embryo-fetal toxicity.",
keywords = "Exposure dose, Exposure timing, Pregnancy registries",
author = "Briggs, {Gerald G.} and Janine Polifka and Elizabeth Balken and Anick Berard and Stephen Braddock and Christina Chambers and Adrienne Einarson and Gaffaney, {Cecilia Lyons} and Dee Quinn and Gideon Koren and Kenneth Jones and Steve Lamm and Richard Miller and Sara Riordan and Luther Robinson and Offie Soldin and Katherine Wisner and Lori Wolfe",
year = "2009",
month = "2",
day = "1",
doi = "10.1002/bdra.20551",
language = "English (US)",
volume = "85",
pages = "109--111",
journal = "Teratology",
issn = "1542-0752",
publisher = "Wiley-Liss Inc.",
number = "2",

}

Briggs, GG, Polifka, J, Balken, E, Berard, A, Braddock, S, Chambers, C, Einarson, A, Gaffaney, CL, Quinn, D, Koren, G, Jones, K, Lamm, S, Miller, R, Riordan, S, Robinson, L, Soldin, O, Wisner, K & Wolfe, L 2009, 'Better data needed from pregnancy registries', Birth Defects Research Part A - Clinical and Molecular Teratology, vol. 85, no. 2, pp. 109-111. https://doi.org/10.1002/bdra.20551

Better data needed from pregnancy registries. / Briggs, Gerald G.; Polifka, Janine; Balken, Elizabeth; Berard, Anick; Braddock, Stephen; Chambers, Christina; Einarson, Adrienne; Gaffaney, Cecilia Lyons; Quinn, Dee; Koren, Gideon; Jones, Kenneth; Lamm, Steve; Miller, Richard; Riordan, Sara; Robinson, Luther; Soldin, Offie; Wisner, Katherine; Wolfe, Lori.

In: Birth Defects Research Part A - Clinical and Molecular Teratology, Vol. 85, No. 2, 01.02.2009, p. 109-111.

Research output: Contribution to journalShort survey

TY - JOUR

T1 - Better data needed from pregnancy registries

AU - Briggs, Gerald G.

AU - Polifka, Janine

AU - Balken, Elizabeth

AU - Berard, Anick

AU - Braddock, Stephen

AU - Chambers, Christina

AU - Einarson, Adrienne

AU - Gaffaney, Cecilia Lyons

AU - Quinn, Dee

AU - Koren, Gideon

AU - Jones, Kenneth

AU - Lamm, Steve

AU - Miller, Richard

AU - Riordan, Sara

AU - Robinson, Luther

AU - Soldin, Offie

AU - Wisner, Katherine

AU - Wolfe, Lori

PY - 2009/2/1

Y1 - 2009/2/1

N2 - This article is a consensus position statement from the Research Committee of the Organization of Teratology Information Specialists (OTIS). The Committee believes that more specific information on the timing and dose of drug exposures from pregnancy birth defect registries sponsored by pharmaceutical companies (herein called pregnancy registries) would improve the estimation of risk for developmental toxicity (i.e., growth alteration, structural anomalies, functional/neurobehavioral deficits, or death). Specifically, the Committee believes that the exposure timing should be stated in gestational weeks and days rather than simply weeks. In addition, the Committee believes that the exposure dose should be stated in patient-specific terms, such as body weight (mg/kg) or body surface area (mg/m2) rather than simply dose strength. Although the focus of this position is pregnancy registries, it also is applicable to any source of medication-induced embryo-fetal toxicity.

AB - This article is a consensus position statement from the Research Committee of the Organization of Teratology Information Specialists (OTIS). The Committee believes that more specific information on the timing and dose of drug exposures from pregnancy birth defect registries sponsored by pharmaceutical companies (herein called pregnancy registries) would improve the estimation of risk for developmental toxicity (i.e., growth alteration, structural anomalies, functional/neurobehavioral deficits, or death). Specifically, the Committee believes that the exposure timing should be stated in gestational weeks and days rather than simply weeks. In addition, the Committee believes that the exposure dose should be stated in patient-specific terms, such as body weight (mg/kg) or body surface area (mg/m2) rather than simply dose strength. Although the focus of this position is pregnancy registries, it also is applicable to any source of medication-induced embryo-fetal toxicity.

KW - Exposure dose

KW - Exposure timing

KW - Pregnancy registries

UR - http://www.scopus.com/inward/record.url?scp=62949200322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62949200322&partnerID=8YFLogxK

U2 - 10.1002/bdra.20551

DO - 10.1002/bdra.20551

M3 - Short survey

C2 - 19107958

AN - SCOPUS:62949200322

VL - 85

SP - 109

EP - 111

JO - Teratology

JF - Teratology

SN - 1542-0752

IS - 2

ER -

Briggs GG, Polifka J, Balken E, Berard A, Braddock S, Chambers C et al. Better data needed from pregnancy registries. Birth Defects Research Part A - Clinical and Molecular Teratology. 2009 Feb 1;85(2):109-111. https://doi.org/10.1002/bdra.20551